HACE1 Polyclonal Antibody

This gene encodes a HECT domain and ankyrin repeat-containing ubiquitin ligase. The encoded protein is involved in specific tagging of target proteins, leading to their subcellular localization or proteasomal degradation. The protein is a potential tumor suppressor and is involved in the pathophysiology of several tumors, including Wilm's tumor.

The HACE1 Polyclonal Antibody is a highly specific and sensitive tool designed for the detection and analysis of HACE1 protein expression in various biological samples. This antibody is produced using advanced immunization techniques, ensuring high affinity and specificity towards HACE1.

HACE1, also known as HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1, is a crucial regulator of cellular processes such as protein degradation and ubiquitination. Dysregulation of HACE1 has been implicated in various diseases, including cancer and neurodegenerative disorders.

The HACE1 Polyclonal Antibody exhibits exceptional performance in a wide range of applications, including Western blotting, immunohistochemistry, and immunofluorescence. It recognizes endogenous levels of HACE1 protein in human, mouse, and rat samples, providing reliable and reproducible results.

With its high sensitivity and specificity, the HACE1 Polyclonal Antibody is an invaluable tool for researchers and scientists studying the role of HACE1 in cellular processes and disease pathogenesis. Its superior performance and versatility make it an essential component of any laboratory focused on protein analysis and characterization.

Order the HACE1 Polyclonal Antibody today and unlock new insights into the intricate mechanisms governed by HACE1, advancing your research and contributing to the scientific community's understanding of this vital protein.